<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-03T20:32:32+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2696】【2020金研奖】徐建明教授：国内临床研究格局已翻天覆地，期待更多原创性研究</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/JBtNIRSmeVc0vFFdMKavVQ</id>
    <link href="https://mp.weixin.qq.com/s/JBtNIRSmeVc0vFFdMKavVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【柳叶刀】KEYNOTE-355研究：Ⅲ期临床显示帕博利珠单抗联合化疗增强三阴性乳腺癌患者生存获益</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/wLbJaStJV8Ol-oew292DqA</id>
    <link href="https://mp.weixin.qq.com/s/wLbJaStJV8Ol-oew292DqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【12】2019版CSCO乳腺癌诊疗指南 绝经前激素受体阳性患者的治疗策略解读</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/f8salWgbQQwLLG7fNwvzoQ</id>
    <link href="https://mp.weixin.qq.com/s/f8salWgbQQwLLG7fNwvzoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2695】【Nature Research】中山大学孙逸仙纪念医院：中国西医先行者，引领抗击乳腺癌前沿</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/QLmOb4wOmDmfzAIvtafF-Q</id>
    <link href="https://mp.weixin.qq.com/s/QLmOb4wOmDmfzAIvtafF-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】2020年度盘点|泌尿系肿瘤免疫治疗进展年度盘点</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/uQXjdXpQ0KqXwl_izf63tg</id>
    <link href="https://mp.weixin.qq.com/s/uQXjdXpQ0KqXwl_izf63tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【JCO】DARPin一类候选新药：VEGF/HGF抑制剂MP0250首次人体实体瘤应用</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/vLDa76PO42SEqqLL21Q4mw</id>
    <link href="https://mp.weixin.qq.com/s/vLDa76PO42SEqqLL21Q4mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【速递】阿帕替尼获批新适应证，肝细胞癌靶向治疗再添利器！</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/KRVi90_k7dc0sxe1Cepnrw</id>
    <link href="https://mp.weixin.qq.com/s/KRVi90_k7dc0sxe1Cepnrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2694】2020 IASLC WCLC大幕即将拉开，大会主席吴一龙教授邀您来参会啦！</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/candPOVrf80ovbfLsE_DPw</id>
    <link href="https://mp.weixin.qq.com/s/candPOVrf80ovbfLsE_DPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>舒心可依患者救助项目 3.98万元封顶且门槛价低，患者可及性更高</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/WWNiZwrVTAeQQimmOOY8NQ</id>
    <link href="https://mp.weixin.qq.com/s/WWNiZwrVTAeQQimmOOY8NQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】2020年度盘点|泌尿系肿瘤免疫治疗进展年度盘点</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/A1n5rU6a2FDenm1vE6wTtA</id>
    <link href="https://mp.weixin.qq.com/s/A1n5rU6a2FDenm1vE6wTtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“泌尿肿瘤免疫治疗系列沙龙”揭开面纱，传递前沿进展，促进免疫治疗规范化</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/i5NZlh7lnDVk5K4SBwsBAw</id>
    <link href="https://mp.weixin.qq.com/s/i5NZlh7lnDVk5K4SBwsBAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2693】年度巨制丨「骨与软组织肿瘤药物盘点」即将重磅上线！</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/KFLgR7RbOSWY4Q5WuJF3zA</id>
    <link href="https://mp.weixin.qq.com/s/KFLgR7RbOSWY4Q5WuJF3zA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>直肠癌个体化新辅助治疗的决策：以终为始 分而治之</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/PdCQE37ygn3ABWDfBy6_Hg</id>
    <link href="https://mp.weixin.qq.com/s/PdCQE37ygn3ABWDfBy6_Hg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PFS竟然长达16个月！直肠癌术后肺转移患者，多线治疗后如何优选治疗策略</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/_GnEXIntMHPFukcoSmEb9g</id>
    <link href="https://mp.weixin.qq.com/s/_GnEXIntMHPFukcoSmEb9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧狄沃患者援助方案再更新！年自付费用降幅超75%，多瘤种获益</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/fYHjFu2nR5ve-hCyV8Y9xA</id>
    <link href="https://mp.weixin.qq.com/s/fYHjFu2nR5ve-hCyV8Y9xA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【11】 中国早期乳腺癌卵巢功能抑制临床应用专家共识 (2018年版)解读</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/V-y5GGRfF7NStVW7idrzyg</id>
    <link href="https://mp.weixin.qq.com/s/V-y5GGRfF7NStVW7idrzyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【用“实例”说话】肝癌合并门静脉癌栓，局部联合全身治疗全程管理，生存期已逾15个月</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/u3BTxfVlkCZnjyFDx9x8pQ</id>
    <link href="https://mp.weixin.qq.com/s/u3BTxfVlkCZnjyFDx9x8pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 索凡替尼正式获批，非胰腺神经内分泌瘤斩获新药！</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/0WGhYSc87bcdmfQo2idJEw</id>
    <link href="https://mp.weixin.qq.com/s/0WGhYSc87bcdmfQo2idJEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内第2款CDK4/6抑制剂阿贝西利正式获批上市，晚期激素受体阳性乳腺癌患者选择更加多元化</title>
    <updated>2020-12-31T19:38:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/4iTwiYXwaRNkUKXBdcv79Q</id>
    <link href="https://mp.weixin.qq.com/s/4iTwiYXwaRNkUKXBdcv79Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2692】【2020金研奖】周彩存教授：有了靶向治疗，有了免疫治疗，肺癌逐步会成为慢性病</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/V8rqIazeHGODPsqfuGJR8A</id>
    <link href="https://mp.weixin.qq.com/s/V8rqIazeHGODPsqfuGJR8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>